Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
NPCE - Neuropace, Inc.
Market Cap 106.70M P/E - EPS this Y 14.20% Ern Qtrly Grth -
Income -29.9M Forward P/E -2.58 EPS next Y 3.70% 50D Avg Chg -2.00%
Sales 71.82M PEG - EPS past 5Y - 200D Avg Chg 17.00%
Dividend N/A Price/Book 3.87 EPS next 5Y - 52W High Chg -32.00%
Recommedations 1.90 Quick Ratio 5.31 Shares Outstanding 29.20M 52W Low Chg 244.00%
Insider Own 4.19% ROA -15.75% Shares Float 12.11M Beta 1.81
Inst Own 83.89% ROE -192.19% Shares Shorted/Prior 506.36K/488.29K Price 4.20
Gross Margin 74.15% Profit Margin -41.63% Avg. Volume 10,770 Target Price 15.50
Oper. Margin -32.35% Earnings Date Nov 4 Volume 7,235 Change 0.96%
Healthcare | Medical Devices | United States
About Neuropace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Neuropace, Inc. News
12/18/24 NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/12/24 NeuroPace to Host Investor Day on January 28th in New York City
12/06/24 Wall Street Analysts Think NeuroPace (NPCE) Could Surge 31.47%: Read This Before Placing a Bet
12/04/24 NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting
12/03/24 NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome
11/18/24 What Makes NeuroPace (NPCE) a New Buy Stock
11/18/24 Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade
11/14/24 NeuroPace Third Quarter 2024 Earnings: Beats Expectations
11/13/24 NeuroPace Inc (NPCE) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ...
11/12/24 NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates
11/12/24 NeuroPace Inc.: Q3 Earnings Snapshot
11/12/24 NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
11/09/24 private equity firms who own 45% along with institutions invested in NeuroPace, Inc. (NASDAQ:NPCE) saw increase in their holdings value last week
11/04/24 NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
10/28/24 Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength?
10/22/24 NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024
10/16/24 NeuroPace Continues to Strengthen Management Team
09/04/24 NeuroPace Strengthens Management Team with Two Key Appointments
08/27/24 NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
08/22/24 NeuroPace to Participate in Upcoming Healthcare Conferences in September
NPCE Chatroom

User Image NVDAMillionaire Posted - 1 week ago

$NPCE NeuroPace, Inc. (NPCE): A Compelling Epilepsy Treatment Leader Navigating Solid Growth https://beyondspx.com/article/neuropace-inc-npce-a-compelling-epilepsy-treatment-leader-navigating-solid-growth

User Image Joaquin_Guzman5 Posted - 2 weeks ago

$TMDX medtechs always got crazy swings look at $swav $npce chart lol

User Image TradeMark79 Posted - 1 month ago

$ICU …Still holding but been riding $NPCE…GLTA!

User Image BioHype Posted - 1 month ago

$NPCE we got a runner!

User Image PenkeTrading Posted - 1 month ago

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Neuropace Inc. Is that bullish or bearish? $NPCE #Neuropace #RsiOverbought #NASDAQ

User Image Joaquin_Guzman5 Posted - 1 month ago

$NPCE boooming

User Image TradeMark79 Posted - 1 month ago

$NPCE …Loaded…Long here!..GLTA!

User Image RocketThief Posted - 1 month ago

$NPCE told ya

User Image DonCorleone77 Posted - 1 month ago

$NPCE NeuroPace raises FY24 revenue view to $78M-$80M from $76M-$78M Consensus $77.1M. Sees FY24 gross margin 72%-74%. The company said, "NeuroPace continues to expect revenue growth to be primarily driven by increasing sales of its RNS System, supported by higher sales of DIXI Medical stereo EEG products."

User Image DonCorleone77 Posted - 1 month ago

$NPCE NeuroPace reports Q3 EPS (19c), consensus (27c) Reports Q3 revenue $21.06M, consensus $19.08M. "I am very pleased with our performance in the third quarter, both with regard to record revenue and a further reduction in our cash burn as a result of our ongoing commitment to operating discipline. We have also strengthened our leadership team to further capitalize on this momentum and position NeuroPace to take full advantage of the exciting opportunities in front of us," said Joel Becker, Chief Executive Officer of NeuroPace. "Looking ahead, we see tremendous opportunity to grow our business as we continue to execute our strategy of increasing access to RNS therapy by expanding within our current customer base at Comprehensive Epilepsy Centers, broadening site of service through Project CARE, and adding new indications for use to help close the treatment gap for drug-resistant epilepsy patients."

User Image RocketThief Posted - 1 month ago

$NPCE wow! Beat consensus, increased guidance, great margins, very low burn (so close to profitability), increased total cash balance…what more does this company need to do?!

User Image RocketThief Posted - 1 month ago

$NPCE gift territory

User Image RocketThief Posted - 1 month ago

$LUNG $NPCE 🔥

User Image DonCorleone77 Posted - 1 month ago

$NPCE NeuroPace submits safety, effectiveness data from RNS System study to FDA NeuroPace announced FDA submission of three-year safety and effectiveness data from its prospective post-approval study of the RNS System in adults with drug-resistant focal epilepsy. The study enrolled more than three hundred patients from more than thirty leading Level 4 Comprehensive Epilepsy Centers in the United States, making it the largest prospectively enrolled trial in the field of neuromodulation for drug-resistant focal epilepsy.

User Image BrokenZipper Posted - 10/30/24

$NPCE Let's get above 7.09 and let the games begin

User Image insiderbuyingselling Posted - 10/28/24

$NPCE new insider selling: 224138 shares. http://insiderbuyingselling.com/?t=NPCE

User Image swingingtech Posted - 10/28/24

$NPCE $MASI https://wallstreetwaves.com/strength-seen-in-neuropace-npce-can-its-5-1-jump-turn-into-more-strength/

User Image Stocksrunner Posted - 10/25/24

Big bounce! These stocks hit their lows but came back stronger: $SGMO $NPCE $TFFP $BURU $WBX 🚀 Keep an eye on these resilient movers!

User Image _www_larval_com_ Posted - 10/25/24

$NXL -11%[3%] $DRUG 4%[0%] $UPXI -4%[167%] $NPCE 3%[7%] $MNPR 3%[-45%] most notable movement into the final minutes of trading.

User Image RocketThief Posted - 10/25/24

$NPCE huge volume, what’s the scoop?

User Image insiderbuyingselling Posted - 10/24/24

$NPCE new insider selling: 4082 shares. http://insiderbuyingselling.com/?t=NPCE

User Image insiderbuyingselling Posted - 2 months ago

$NPCE new insider selling: 8598 shares. http://insiderbuyingselling.com/?t=NPCE

User Image RocketThief Posted - 2 months ago

$NPCE $LUNG when high quality medtech stocks dip on very low volumes, that is a screaming buy. Loading the hell out of these in low $6s

Analyst Ratings
Cantor Fitzgerald Overweight Aug 14, 24
Wells Fargo Overweight Aug 14, 24
Morgan Stanley Equal-Weight Jul 15, 24
Cantor Fitzgerald Overweight May 9, 24
Wells Fargo Overweight Mar 14, 24
JP Morgan Overweight Mar 12, 24
Cantor Fitzgerald Overweight Mar 6, 24
Morgan Stanley Equal-Weight Mar 6, 24
Wells Fargo Equal-Weight Feb 22, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Morrell Martha Chief Medical Office.. Chief Medical Officer Feb 02 Sell 15.12 17,589 265,946 77,762 02/06/24
Morrell Martha Chief Medical Office.. Chief Medical Officer Jan 30 Sell 15.07 13,848 208,689 95,351 02/01/24
Morrell Martha Chief Medical Office.. Chief Medical Officer Jan 24 Sell 15.01 828 12,428 109,199 01/26/24
Morrell Martha Chief Medical Office.. Chief Medical Officer Dec 26 Sell 10.06 13,402 134,824 110,027 12/28/23
KCK LTD. 10% Owner 10% Owner Nov 29 Sell 8.76 16,167 141,623 5,593,773 12/01/23
KCK LTD. Director Director Nov 27 Sell 8.86 11,171 98,975 5,609,940 11/29/23
ORBIMED ADVISORS LLC 10% Owner 10% Owner Oct 02 Sell 9.05 8,314 75,242 4,003,967 10/04/23
Kuhn Rebecca Chief Financial Offi.. Chief Financial Officer Oct 31 Option 0.03 1,428 43 59,704 11/02/22
LACOB JOSEPH Director Director Oct 18 Option 0.026 192 5 384 10/20/22
Ridley Irina General Counsel and.. General Counsel and Secretary Jun 08 Sell 5.778 2,500 14,445 61,139 06/09/22
Ridley Irina General Counsel and.. General Counsel and Secretary Feb 28 Sell 7.5386 1,470 11,082 6,652 03/01/22